002390.KS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 14:30):

Handok Inc. operates as an integrated pharmaceutical company. The company provides ETC and OTC drugs, medical devices, and in-vitro diagnostics instruments and devices...

Stats
今日成交量	24 812.00
平均成交量	20 939.00
市值	187.05B
EPS	KRW0 ( 2024-05-03 )
下一个收益日期	( KRW0 ) 2024-07-25
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW7.77 (0.06%)

音量相关性

長: -0.07 (neutral)

短: 0.00 (neutral)

Signal:(57.706) Neutral

HANDOK Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

HANDOK Inc. 相关性 - 货币/商品

0.44
( neutral )

0.43
( neutral )

0.06
( neutral )

0.59
( weak )

-0.35
( neutral )

HANDOK Inc. 财务报表

Annual	2023
营收:	KRW522.74B
毛利润:	KRW151.37B (28.96 %)
EPS:	KRW-2 091.39

FY	2023
营收:	KRW522.74B
毛利润:	KRW151.37B (28.96 %)
EPS:	KRW-2 091.39

FY	2022
营收:	KRW543.76B
毛利润:	KRW173.71B (31.95 %)
EPS:	KRW775.88

FY	2021
营收:	KRW517.64B
毛利润:	KRW167.55B (32.37 %)
EPS:	KRW239.28

Financial Reports:

No articles found.

HANDOK Inc.

Handok Inc. operates as an integrated pharmaceutical company. The company provides ETC and OTC drugs, medical devices, and in-vitro diagnostics instruments and devices. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet and Culturelle brands; food and beverages; and medical nutrition products. Handok Inc. has a strategic collaboration agreement with AUM Biosciences Pte. Ltd. and CMG Pharmaceutical Co. Ltd. for the development, manufacturing, and commercialization of CHC2014, a pan-TRK inhibitor for cancer treatment. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is based in Seoul, South Korea.